Skip to main content

Advertisement

Table 3 Logistic regression: Predictive factors for response to IFX induction therapy at week 12 in Crohn's disease

From: Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study

Factor Coefficient Pvalue OR 95% CI
Gender 0,070 0.828 - -
Longer disease duration (≤ 10 years vs. > 10 years) -1.161 < 0.001 0.349 0.165-0.596
Disease behavior -0,312 0.349 - -
Concomitant AZA/methotrexate use 0.710 0.05 2.03 1.001-4.168
Steroid use -0,438 0.184 - -
  1. The coefficient is equivalent to the natural log of the OR; p value: level of significance;
  2. OR: odds ratio; 95% CI: 95% confidence interval.